Navigation Links
Do anaesthetics trigger stress?
Date:9/24/2013

New research could improve the welfare standards of millions of fish used by scientists around the world. The study, published in PLOS ONE, is one of the first to formally assess the welfare implications of anaesthetics on fish. Researchers use fish to study the developmental origins of health and disease.

The work, carried out in collaboration between the University of Bristol's School of Veterinary Sciences and AstraZeneca Brixham Environmental Laboratory, investigated whether scientists are using the right anaesthetics and if current best practice for fish could be improved.

The research team's behavioural study evaluated nine of the most commonly used anaesthetics and performed preference tests using adult mixed sex zebrafish (Danio rerio), the most commonly held laboratory fish, to record their responses. Video tracking software measured swimming behaviour related to dislike for each anaesthetic at 50 per cent of its standard recommended dose compared with clean water in a flow-through chemotaxic choice chamber.

The aim of the research was to find out if anaesthetic compounds cause changes in the swimming behaviour of the zebrafish and whether the potential stress induced in these animals is inhumane.

Zebrafish embryos are transparent and develop outside the body, allowing simple study of the developing embryo. Zebrafish research provides a unique visual approach to understanding the developmental defects in adult diseases and age-related abnormalities, such as cardiovascular diseases.

Dr Jo Murrell, Senior Lecturer in Veterinary Anaesthesia at the Vet School and co-author on the study with Gareth Readman, Bristol PhD student and fish biologist at AstraZeneca, said: "Zebrafish are the most commonly used fish in universities and research organisations. There is a need to use anaesthetics to help handle them, collect samples, or humanely euthanise them.

"With tens of millions of fish used in science around the world, it is very important that the anaesthetics used to do this are the most humane available and do not themselves cause a stress response. "

The team found that several commonly used anaesthetics were aversive, including two of the most commonly recommended and used: MS222 (ethyl 3-aminobenzoate methanesulphate) and benzocaine. For ethical best practice, it is recommended that compounds that are aversive, even at low concentration, should no longer be used routinely for anaesthesia or for the first step of humane euthanasia of adult zebrafish.

Two agents were found not to induce aversive behavioural responses: etomidate and 2,2,2 tribromoethanol.

For the millions of adult zebrafish used in laboratories and breeding worldwide, the research team found the anaesthetic etomidate appears best suited for future routine humane use.

There have been advancements in general veterinary anaesthesia for mammals, but fish have been left behind and the research team hope this work will begin to re-address that balance.


'/>"/>

Contact: Joanne Fryer
joanne.fryer@bristol.ac.uk
44-011-733-17276
University of Bristol
Source:Eurekalert

Related biology news :

1. A single stem cell mutation triggers fibroid tumors
2. NIH-led study finds genetic test results do not trigger increased use of health services
3. Scientists discover new trigger for immense North Atlantic plankton bloom
4. Deadly liver cancer may be triggered by cells changing identity, UCSF study shows
5. Common parasite may trigger suicide attempts
6. Finding triggers of birth defects in an embryo heart
7. NIH-funded researchers show possible trigger for MS nerve damage
8. Rice uses light to remotely trigger biochemical reactions
9. Newly discovered scarecrow gene might trigger big boost in food production
10. Popular energy drinks trigger caffeine jitters
11. Key protein revealed as trigger for stem cell development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce the attainment of record-setting ... result of the company,s laser focus on (and growing ... it,s comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... MedNet growth achievements in 2015 include: , ...
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
(Date:1/11/2016)... Synaptics Incorporated (NASDAQ: SYNA ), the ... its ClearPad ® TouchView ™ 4300 touch ... categories in the 8 th Annual Mobile Excellence ... The Synaptics ® TDDI solution enables faster time-to-market, ... devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... Brooklyn, NY (PRWEB) , ... February 04, 2016 , ... ... cuvettes for over 10 years. What sets them apart from other cuvette ... that is posted on their website. On top of this steady flow of ...
(Date:2/3/2016)... 2016 Ascendis Pharma A/S (Nasdaq: ASND ... innovative TransCon technology to address significant unmet medical needs, ... conference.Event:2016 Leerink Partners Global Healthcare Conference Location: , ... 10, 2016 Time:  , 11:55am EST ... An audio webcast of this event will be ...
Breaking Biology Technology: